Copyright Reports & Markets. All rights reserved.

Global Osteoarthritis Pain Drugs Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Osteoarthritis Pain Drugs Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Osteoarthritis Pain Drugs Market Size Growth Rate by Type
    • 1.4.2 Oral
    • 1.4.3 Injection
    • 1.2.4 External
  • 1.3 Market by Application
    • 1.3.1 Global Osteoarthritis Pain Drugs Market Size Growth Rate by Application
    • 1.3.2 Medical Care
    • 1.3.3 Personal Care
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Osteoarthritis Pain Drugs Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Osteoarthritis Pain Drugs Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Osteoarthritis Pain Drugs Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Osteoarthritis Pain Drugs Regions by Sales
    • 2.4.1 Global Top Osteoarthritis Pain Drugs Regions by Sales (2016-2021)
    • 2.4.2 Global Top Osteoarthritis Pain Drugs Regions by Sales (2022-2027)
  • 2.5 Global Top Osteoarthritis Pain Drugs Regions by Revenue
    • 2.5.1 Global Top Osteoarthritis Pain Drugs Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Osteoarthritis Pain Drugs Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Osteoarthritis Pain Drugs Sales by Manufacturers
    • 3.1.1 Global Top Osteoarthritis Pain Drugs Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Osteoarthritis Pain Drugs Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Osteoarthritis Pain Drugs Sales in 2020
  • 3.2 Global Osteoarthritis Pain Drugs Revenue by Manufacturers
    • 3.2.1 Global Top Osteoarthritis Pain Drugs Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Osteoarthritis Pain Drugs Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Osteoarthritis Pain Drugs Revenue in 2020
  • 3.3 Global Osteoarthritis Pain Drugs Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Osteoarthritis Pain Drugs Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Osteoarthritis Pain Drugs Sales by Type
    • 4.1.1 Global Osteoarthritis Pain Drugs Historical Sales by Type (2016-2021)
    • 4.1.2 Global Osteoarthritis Pain Drugs Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2027)
  • 4.2 Global Osteoarthritis Pain Drugs Revenue by Type
    • 4.2.1 Global Osteoarthritis Pain Drugs Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Osteoarthritis Pain Drugs Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2016-2027)
  • 4.3 Global Osteoarthritis Pain Drugs Price by Type
    • 4.3.1 Global Osteoarthritis Pain Drugs Price by Type (2016-2021)
    • 4.3.2 Global Osteoarthritis Pain Drugs Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Osteoarthritis Pain Drugs Sales by Application
    • 5.1.1 Global Osteoarthritis Pain Drugs Historical Sales by Application (2016-2021)
    • 5.1.2 Global Osteoarthritis Pain Drugs Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2027)
  • 5.2 Global Osteoarthritis Pain Drugs Revenue by Application
    • 5.2.1 Global Osteoarthritis Pain Drugs Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Osteoarthritis Pain Drugs Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2016-2027)
  • 5.3 Global Osteoarthritis Pain Drugs Price by Application
    • 5.3.1 Global Osteoarthritis Pain Drugs Price by Application (2016-2021)
    • 5.3.2 Global Osteoarthritis Pain Drugs Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Osteoarthritis Pain Drugs Market Size by Type
    • 6.1.1 North America Osteoarthritis Pain Drugs Sales by Type (2016-2027)
    • 6.1.2 North America Osteoarthritis Pain Drugs Revenue by Type (2016-2027)
  • 6.2 North America Osteoarthritis Pain Drugs Market Size by Application
    • 6.2.1 North America Osteoarthritis Pain Drugs Sales by Application (2016-2027)
    • 6.2.2 North America Osteoarthritis Pain Drugs Revenue by Application (2016-2027)
  • 6.3 North America Osteoarthritis Pain Drugs Market Size by Country
    • 6.3.1 North America Osteoarthritis Pain Drugs Sales by Country (2016-2027)
    • 6.3.2 North America Osteoarthritis Pain Drugs Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Osteoarthritis Pain Drugs Market Size by Type
    • 7.1.1 Europe Osteoarthritis Pain Drugs Sales by Type (2017-2027)
    • 7.1.2 Europe Osteoarthritis Pain Drugs Revenue by Type (2017-2027)
  • 7.2 Europe Osteoarthritis Pain Drugs Market Size by Application
    • 7.2.1 Europe Osteoarthritis Pain Drugs Sales by Application (2017-2027)
    • 7.2.2 Europe Osteoarthritis Pain Drugs Revenue by Application (2017-2027)
  • 7.3 Europe Osteoarthritis Pain Drugs Market Size by Country
    • 7.3.1 Europe Osteoarthritis Pain Drugs Sales by Country (2017-2027)
    • 7.3.2 Europe Osteoarthritis Pain Drugs Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Osteoarthritis Pain Drugs Market Size by Type
    • 8.1.1 Asia Pacific Osteoarthritis Pain Drugs Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Osteoarthritis Pain Drugs Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Osteoarthritis Pain Drugs Market Size by Application
    • 8.2.1 Asia Pacific Osteoarthritis Pain Drugs Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Osteoarthritis Pain Drugs Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Osteoarthritis Pain Drugs Market Size by Region
    • 8.3.1 Asia Pacific Osteoarthritis Pain Drugs Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Osteoarthritis Pain Drugs Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Osteoarthritis Pain Drugs Market Size by Type
    • 9.1.1 Latin America Osteoarthritis Pain Drugs Sales by Type (2019-2027)
    • 9.1.2 Latin America Osteoarthritis Pain Drugs Revenue by Type (2019-2027)
  • 9.2 Latin America Osteoarthritis Pain Drugs Market Size by Application
    • 9.2.1 Latin America Osteoarthritis Pain Drugs Sales by Application (2019-2027)
    • 9.2.2 Latin America Osteoarthritis Pain Drugs Revenue by Application (2019-2027)
  • 9.3 Latin America Osteoarthritis Pain Drugs Market Size by Country
    • 9.3.1 Latin America Osteoarthritis Pain Drugs Sales by Country (2019-2027)
    • 9.3.2 Latin America Osteoarthritis Pain Drugs Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Osteoarthritis Pain Drugs Market Size by Type
    • 6.1.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Osteoarthritis Pain Drugs Market Size by Application
    • 6.2.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Osteoarthritis Pain Drugs Market Size by Country
    • 6.3.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Osteoarthritis Pain Drugs Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 U.A.E

11 Company Profiles

  • 11.1 Sino Biopharmaceutical
    • 11.1.1 Sino Biopharmaceutical Corporation Information
    • 11.1.2 Sino Biopharmaceutical Overview
    • 11.1.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Description
    • 11.1.5 Sino Biopharmaceutical Related Developments
  • 11.2 Chugai Pharmaceutical
    • 11.2.1 Chugai Pharmaceutical Corporation Information
    • 11.2.2 Chugai Pharmaceutical Overview
    • 11.2.3 Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Description
    • 11.2.5 Chugai Pharmaceutical Related Developments
  • 11.3 Pfizer
    • 11.3.1 Pfizer Corporation Information
    • 11.3.2 Pfizer Overview
    • 11.3.3 Pfizer Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Pfizer Osteoarthritis Pain Drugs Product Description
    • 11.3.5 Pfizer Related Developments
  • 11.4 Mikasa Seiyaku
    • 11.4.1 Mikasa Seiyaku Corporation Information
    • 11.4.2 Mikasa Seiyaku Overview
    • 11.4.3 Mikasa Seiyaku Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Mikasa Seiyaku Osteoarthritis Pain Drugs Product Description
    • 11.4.5 Mikasa Seiyaku Related Developments
  • 11.5 Bayer
    • 11.5.1 Bayer Corporation Information
    • 11.5.2 Bayer Overview
    • 11.5.3 Bayer Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 Bayer Osteoarthritis Pain Drugs Product Description
    • 11.5.5 Bayer Related Developments
  • 11.6 Haohai Biological
    • 11.6.1 Haohai Biological Corporation Information
    • 11.6.2 Haohai Biological Overview
    • 11.6.3 Haohai Biological Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Haohai Biological Osteoarthritis Pain Drugs Product Description
    • 11.6.5 Haohai Biological Related Developments
  • 11.7 SK Chemicals
    • 11.7.1 SK Chemicals Corporation Information
    • 11.7.2 SK Chemicals Overview
    • 11.7.3 SK Chemicals Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 SK Chemicals Osteoarthritis Pain Drugs Product Description
    • 11.7.5 SK Chemicals Related Developments
  • 11.8 Taisho Pharmaceutical
    • 11.8.1 Taisho Pharmaceutical Corporation Information
    • 11.8.2 Taisho Pharmaceutical Overview
    • 11.8.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Description
    • 11.8.5 Taisho Pharmaceutical Related Developments
  • 11.9 Zhejiang Chengyi Pharmaceutical
    • 11.9.1 Zhejiang Chengyi Pharmaceutical Corporation Information
    • 11.9.2 Zhejiang Chengyi Pharmaceutical Overview
    • 11.9.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.9.4 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Description
    • 11.9.5 Zhejiang Chengyi Pharmaceutical Related Developments
  • 11.10 Freda
    • 11.10.1 Freda Corporation Information
    • 11.10.2 Freda Overview
    • 11.10.3 Freda Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.10.4 Freda Osteoarthritis Pain Drugs Product Description
    • 11.10.5 Freda Related Developments
  • 11.1 Sino Biopharmaceutical
    • 11.1.1 Sino Biopharmaceutical Corporation Information
    • 11.1.2 Sino Biopharmaceutical Overview
    • 11.1.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Description
    • 11.1.5 Sino Biopharmaceutical Related Developments
  • 11.12 Jingfeng Pharmaceutical
    • 11.12.1 Jingfeng Pharmaceutical Corporation Information
    • 11.12.2 Jingfeng Pharmaceutical Overview
    • 11.12.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.12.4 Jingfeng Pharmaceutical Product Description
    • 11.12.5 Jingfeng Pharmaceutical Related Developments
  • 11.13 Seikagaku Corporation
    • 11.13.1 Seikagaku Corporation Corporation Information
    • 11.13.2 Seikagaku Corporation Overview
    • 11.13.3 Seikagaku Corporation Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.13.4 Seikagaku Corporation Product Description
    • 11.13.5 Seikagaku Corporation Related Developments
  • 11.14 GSK
    • 11.14.1 GSK Corporation Information
    • 11.14.2 GSK Overview
    • 11.14.3 GSK Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.14.4 GSK Product Description
    • 11.14.5 GSK Related Developments
  • 11.15 Sanofi
    • 11.15.1 Sanofi Corporation Information
    • 11.15.2 Sanofi Overview
    • 11.15.3 Sanofi Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.15.4 Sanofi Product Description
    • 11.15.5 Sanofi Related Developments
  • 11.16 Crystal Genomics
    • 11.16.1 Crystal Genomics Corporation Information
    • 11.16.2 Crystal Genomics Overview
    • 11.16.3 Crystal Genomics Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.16.4 Crystal Genomics Product Description
    • 11.16.5 Crystal Genomics Related Developments
  • 11.17 Johnson & Johnson
    • 11.17.1 Johnson & Johnson Corporation Information
    • 11.17.2 Johnson & Johnson Overview
    • 11.17.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.17.4 Johnson & Johnson Product Description
    • 11.17.5 Johnson & Johnson Related Developments
  • 11.18 GlaxoSmithKline
    • 11.18.1 GlaxoSmithKline Corporation Information
    • 11.18.2 GlaxoSmithKline Overview
    • 11.18.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.18.4 GlaxoSmithKline Product Description
    • 11.18.5 GlaxoSmithKline Related Developments
  • 11.19 Mylan
    • 11.19.1 Mylan Corporation Information
    • 11.19.2 Mylan Overview
    • 11.19.3 Mylan Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.19.4 Mylan Product Description
    • 11.19.5 Mylan Related Developments
  • 11.20 Lilly
    • 11.20.1 Lilly Corporation Information
    • 11.20.2 Lilly Overview
    • 11.20.3 Lilly Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.20.4 Lilly Product Description
    • 11.20.5 Lilly Related Developments
  • 11.21 Abbott Laboratories
    • 11.21.1 Abbott Laboratories Corporation Information
    • 11.21.2 Abbott Laboratories Overview
    • 11.21.3 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.21.4 Abbott Laboratories Product Description
    • 11.21.5 Abbott Laboratories Related Developments
  • 11.22 Almatica Pharma
    • 11.22.1 Almatica Pharma Corporation Information
    • 11.22.2 Almatica Pharma Overview
    • 11.22.3 Almatica Pharma Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.22.4 Almatica Pharma Product Description
    • 11.22.5 Almatica Pharma Related Developments
  • 11.23 TEVA
    • 11.23.1 TEVA Corporation Information
    • 11.23.2 TEVA Overview
    • 11.23.3 TEVA Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.23.4 TEVA Product Description
    • 11.23.5 TEVA Related Developments
  • 11.24 Iroko Pharmaceuticals
    • 11.24.1 Iroko Pharmaceuticals Corporation Information
    • 11.24.2 Iroko Pharmaceuticals Overview
    • 11.24.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.24.4 Iroko Pharmaceuticals Product Description
    • 11.24.5 Iroko Pharmaceuticals Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Osteoarthritis Pain Drugs Value Chain Analysis
  • 12.2 Osteoarthritis Pain Drugs Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Osteoarthritis Pain Drugs Production Mode & Process
  • 12.4 Osteoarthritis Pain Drugs Sales and Marketing
    • 12.4.1 Osteoarthritis Pain Drugs Sales Channels
    • 12.4.2 Osteoarthritis Pain Drugs Distributors
  • 12.5 Osteoarthritis Pain Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Osteoarthritis Pain Drugs Industry Trends
  • 13.2 Osteoarthritis Pain Drugs Market Drivers
  • 13.3 Osteoarthritis Pain Drugs Market Challenges
  • 13.4 Osteoarthritis Pain Drugs Market Restraints

14 Key Findings in The Global Osteoarthritis Pain Drugs Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Osteoarthritis Pain Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Osteoarthritis Pain Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    Oral
    Injection
    External

    Segment by Application
    Medical Care
    Personal Care

    By Company
    Sino Biopharmaceutical
    Chugai Pharmaceutical
    Pfizer
    Mikasa Seiyaku
    Bayer
    Haohai Biological
    SK Chemicals
    Taisho Pharmaceutical
    Zhejiang Chengyi Pharmaceutical
    Freda
    Bright Future
    Jingfeng Pharmaceutical
    Seikagaku Corporation
    GSK
    Sanofi
    Crystal Genomics
    Johnson & Johnson
    GlaxoSmithKline
    Mylan
    Lilly
    Abbott Laboratories
    Almatica Pharma
    TEVA
    Iroko Pharmaceuticals

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now